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Abstract 
Previous work suggests that titin-based passive tension is a factor in the Frank-Starling 
mechanism of the heart, by increasing length-dependent activation (LDA) through an 
increase in calcium sensitivity at long sarcomere length.  We tested this hypothesis in a 
mouse model (N2B KO model) in which titin-based passive tension is elevated as a result of 
the excision of the N2B element, one of cardiac titin’s spring elements.  LDA was assessed 
by measuring the active tension-pCa (-log[Ca2+]) relationship at sarcomere length (SLs) of 
1.95, 2.10 and 2.30 µm in WT and N2B KO skinned myocardium.  LDA was positively 
correlated with titin-based passive tension, due to an increase in calcium sensitivity at the 
longer SLs in the KO.  For example, at pCa 6.0 the KO:WT tension ratio was 1.28 ± 0.07 
and 1.42 ± 0.04 at SLs of 2.1 and 2.3 µm, respectively.  There was no difference in protein 
expression or phosphorylation of sarcomeric proteins.  We also measured the calcium 
sensitivity after PKA treating the skinned muscle and found that titin-based passive tension 
was also now correlated with LDA, with a slope that was significantly increased compared to 
no PKA treatment.   Finally, we performed isolated heart experiments and measured the 
Frank-Starling relation (slope of developed wall stress-LV volume relation) as well as 
diastolic stiffness (slope of diastolic wall stress – volume relation).  The FSM was more 
pronounced in the N2B KO hearts and the slope of the FSM correlated with diastolic 
stiffness.  These findings support that titin-based passive tension triggers an increase in 
calcium sensitivity at long sarcomere length, thereby playing an important role in the Frank-
Starling mechanism of the heart.   
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Introduction 
The heart has a range of mechanisms at its disposal for adapting output, each tuned to 
take place at different time scales [1].  The acute systolic pressure change in response to 
altered venous return is known as the Frank-Starling mechanism (FSM) of the heart [2, 3].  
The FSM can increase systolic pressure several-fold and is considered an indicator of the 
(patho)physiological state of the heart.  The cellular basis of the FSM is not fully 
understood [2-4], but mounting evidence suggests that increased calcium sensitivity of the 
myofilaments in response to stretch is involved [3, 5], rather than increased calcium 
release [4, 6, 7]. Thus, when sarcomeres are stretched the myofilaments produce more 
force for the same level of calcium [2, 3, 5], i.e., the myofilaments display length-
dependent activation (LDA).  Multiple proteins have been proposed to mediate LDA such 
as the thin-filament based troponin (Tn) complex[1, 8], with a central role likely played by 
threonine 144 of cTnI[9], the thick-filament based proteins cMyBP-C and MLC2 [10, 11], 
and titin, the third myofilament of the cardiac sarcomere [8, 12-16].  Titin is an attractive 
candidate because it constitutes the only filament that directly senses stretch and that 
interacts with both actin and myosin[17].  The present study was focused on the role of 
titin in LDA, using a novel mouse KO model in which one of the spring elements of titin is 
deleted. 
 
Titin is a giant filamentous protein that spans the half-sarcomeric distance from Z-disk to 
M-band[18]. Titin’s I-band region functions as a molecular spring that develops passive 
tension when sarcomeres are stretched[19] and it is now well accepted that titin is 
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important for the diastolic health of the heart [17, 20-22].  The adult heart co-expresses 
the stiff N2B and the more complaint N2BA titin isforms [23]; passive tension can be 
regulated by varying the expression ratio of these two titin isoforms [24, 25], and by 
posttranslational modifications of titin spring elements [26-29].  A role for titin in LDA has 
been suggested by experiments in which titin was degraded by trypsin and LDA was 
reduced [12, 30], and by experiments in which changes in titin-based passive tension due 
to variable passive stress relaxation correlated with changes in LDA [13].  A subsequent 
study showed that LDA in bovine left ventricular myocardium was more pronounced than in 
bovine left atrial myocardium, tissues that have high and low titin-based passive tension, 
respectively [15].  Thus, several studies indicate a role for titin in LDA.  
 
In the aforementioned titin studies it is difficult to exclude an additional contribution of thin 
and thick filament proteins, and thus determine solely the titin-based effect on LDA.  To 
overcome this issue, we used a recently developed N2B KO mouse model in which one of 
the spring elements of cardiac titin (the N2B element) is excised and that as a result 
generates higher passive tensions [20].  Therefore, the N2B KO affords the opportunity to 
study the effect of increased passive tension on LDA in the same tissue type and obtain 
different passive tension levels that do not require trypsin treatment to degrade titin.  
Results show that skinned left ventricular (LV) myocardium of the N2B KO develops higher 
titin-based passive tension than WT myocardium, and that LDA in the N2B KO is increased.  
The physiological significance of our findings is supported by isolated heart experiments 
that revealed a more pronounced FSM in the N2B KO hearts.  
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Methods 
Animal model.  We used the N2B region-deficient mouse model (N2B KO) in which exon 
49 of the titin gene has been deleted, while the remainder of the titin gene is intact [20]. Mice 
were genotyped as described previously [20], with the results confirmed by 1% agarose 
protein gels [31, 32] (Fig. 1A shows an example).  Male N2B KO and WT mice (~6 month 
old) were anesthetized with isoflurane (Abbott Laboratories, Chicago, IL) and sacrificed by 
cervical dislocation. The hearts were rapidly removed, and papillary muscles from the left 
ventricular (LV) were dissected in oxygenated 1X HEPES (NaCl, 133.5 mM; KCl, 5mM; 
NaH2PO4, 1.2mM; MgSO4, 1.2mM; BDM 30 mM; HEPES, 10mM) solution.  The remaining 
LV was quick frozen in liquid nitrogen and stored at -80°C for protein analysis.  The 
papillary muscles were skinned in 1X relaxing solution (RS) (BES 40 mM, EGTA 10 mM, 
MgCl2 6.56mM, ATP 5.88 mM, DTT 1 mM, K-propionate 46.35 mM, creatine phosphate 
15mM, pH 7.0) (chemicals from Sigma-Aldrich, MO, USA) with 1% Triton-X-100 (Pierce, IL, 
USA) overnight at ~3ºC. Muscles were then washed thoroughly with RS and stored for one 
month or less at -20ºC in relaxing solution containing 50% (v/v) glycerol. To prevent protein 
degradation, solutions contained protease inhibitors (phenylmethylsulfonyl fluoride (PMSF), 
0.5mM; leupeptin, 0.04 mM; E64, 0.01 mM).  Experiments were approved by the University 
of Arizona Institutional Animal Care and Use Committee and followed the U.S. National 
Institutes of Health “Using Animals in Intramural Research” guidelines for animal use. 
 
Muscle preparations.  Skinned papillary muscles were dissected into small strips (cross-
sectional area (CSA) ~0.02 mm2; length ~1.2 mm) and small aluminum clips were glued to 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 7
the ends of the muscle [33] in order to attach the muscle at one end to a force transducer 
(model 406, Aurora Scientific) and at the other end to a length controller (model 322C, 
Aurora Scientific), which were mounted on top of an inverted microscope stage.  The stage 
contained 6 wells with different solutions in which the muscles could be placed (model 600A, 
Aurora Scientific). The muscles were imaged with a CCD camera, and sarcomere length 
was measured on-line from the striation image using a spatial autocorrelation function 
(model 901, Aurora scientific). The wells were temperature controlled at 15 oC. We 
measured the thickness and width of the preparation and, assuming an elliptical cross-
section, we calculated CSA.  The CSA was used to convert measured forces into tension 
(in mN/mm2).   
 
Skinned muscle solutions.  We used relaxing solution (RS), pre-activating solution (Pre-
A), and maximal activating solution (AS).  All solutions contained the following (mM): BES, 
40mM; DTT, 1 mM; creatine phosphate (PCr), 33 mM; creatine phosphokinase (CPK), 240 
U/ml; the ionic strength was adjusted to 180mM with K-proprionate; pH 7.0 at 15°C.    
Solution MgCl2 Na-ATP EGTA Ca-EGTA K-Propionate
Relaxing 6.86 5.96 10 - 3.28 
Pre-activating 6.66 5.98 1 - 30.44 
Activating 6.64 6.23 - 10 2.09 
The solutions contained protease inhibitors (phenylmethylsulfonyl fluoride (PMSF), 0.5 mM; 
Leupeptin, 0.04 mM; E64, 0.01 mM).   Sub-maximal activating solutions were obtained by 
mixing RS and AS with the free [Ca2+] calculated according to Fabiato and Fabiato [34]. 
 
Experimental Protocol.  Relaxed fibers were set at a sarcomere length (SL) of 1.95 µm.  
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The fibers were activated in the following sequence:  pre-activating solution, pCa 4.5, 
relaxing solution, pre-activating solution, pCa 6.05, 5.85, 5.75, 5.6, and 4.5, relaxing solution. 
The pCa 4.5 activation at the beginning and end were used to calculate the rundown.  This 
sequence was carried out at three SLs: 1.95, 2.1 and 2.3 µm.  For the two latter sequences 
the fibers were stretched (20% L0/s), held for 5 min to allow for stress relaxation, followed by 
pre-activating solution and a pCa 4.5 maximal activation, and then relaxation and a release 
back to the slack length (see a description in Fig.3A).  The protocol was then repeated 
except that now the muscles were exposed to progressively increasing pCa activating 
solutions.  At the end of the third sequence the fibers were once more activated at SL 1.95 
µm to obtain the rundown of the whole experiment which included three force-pCa curves 
(13 ± 2 % for KO (n=8) and 15 ± 2 % for WT(n=8)).  Measured tensions at each sub-
maximal activation were normalized by the maximal activation tension, and the normalized 
tensions were plotted against the pCa, to determine the tension-pCa curve. Passive 
tensions were measured just prior to activation.  To determine titin and collagen 
contribution to passive tension, thick and thin filaments were extracted, removing titin’s 
anchors in the sarcomere, by incubating the skinned muscle in relaxing solution containing 
0.6 M KCl and then in relaxing solution containing 1.0 M KI for 30 min each [25]. The 
remaining tension, assumed to be collagen based, was subtracted from the pre-extraction 
tensions to determine titin-based tensions. 
 
In a subset of experiments we studied the effect of PKA treating the skinned muscle (1hr 
incubation at room temperature with relaxing solution containing 1U/ul catalytic subunit of 
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PKA (Sigma)).  We measured the force-pCa relation at SL 1.95 µm and 2.3 um before and 
after PKA treatment. 
 
Analysis. The tension-pCa curves were fit to the Hill equation: T/Tmax (relative tension) = 
[Ca2+]nH / (K+[Ca2+]nH ), where nH is the Hill coefficient, and pCa50=(-logK)/nH, pCa for half-
maximal activation was calculated. This pCa50 was used as an indicator of calcium sensitivity. 
For each muscle we determined the differences between pCa50 of the tension-pCa curves 
measured at SL 1.95, 2.1 and 2.3 µm and used this as an index of the length-dependent 
activation (i.e. ∆ pCa50). 
 
Gel-electrophoresis, Western blotting, and assessing phosphorylation.  Muscle 
samples from left ventricular (LV) were analyzed by SDS–PAGE.  Muscles were solubilized 
in 8M Urea buffer (8M Urea, 2M Thiourea, 3% SDS, 75mM DTT, 0.05M Tris-HCl, 0.03% 
bromophenol blue) and 50% glycerol with Leupeptin, E-64, and PMSF inhibitors. The protein 
solutions were incubated 10 min at 60°C, centrifuged for 5 min at 12,580xg to remove the 
particulate fraction, and then the proteins were separated by electrophoresis.  For titin 
studies, solubilized samples were run on 1% SDS–agarose gels, electrophoresed at 15mA 
per gel for 3hrs and 20min, at 4°C, as previously described ([31] [32]).  The gels were 
stained with Coomassie Blue (CB), and subsequently scanned and analyzed using One-D 
scan EX software (Scanalytics Inc., Rockville, MD, USA).  For MHC isoform identification, 
7% acrylamide (acrylamide:bis-acrylamide ratio: 37.5:1) gels were used with a 4% 
acrylamide stack, and gels were stained with a standard silver-stain protocol. The gels were 
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run for 24 hrs at 4°C and a constant voltage of 275 V.  For thin-filament-based regulatory 
protein analyses (cTnI, cTnT, Tm-α), 12% acrylamide gels were used; for MLC-2 isoform, 
15% acrylamide (acrylamide:bis-acrylamide ratio: 37.5:1) gels were used, each with a 4% 
acrylamide stack.  The 12% and 15% acrylamide gels were run for 2hrs at room 
temperature at a constant voltage of 100V.  For cMyBP-C isoform identification, 6% 
acrylamide (acrylamide:bis-acrylamide ratio: 37.5:1) gels were used with a 4% acrylamide 
stack, and run at room temperature for 3hrs at 50V and for another 3hrs at 100V.  The 
same running buffer (Tris-base 0.05M, Glycine 0.384M, SDS 0.1% w/v) was used for all gels, 
and the cross-linker ratio of acrylamide gels was for both resolving and stacking gels 37.5:1 
(Acrylamide:Bis-acrylamide).   
 
For each protein, western blotting procedure was performed using specific antibodies (cTnI, 
Goat anti-cardiac TnI, Santa Cruz sc-31655; cTnT, Mouse anti-cardiac TnT, Santa Cruz sc-
52285; α-Tm, Mouse anti-Tm, Hybridoma Bank CH1; cMyBP-C, Goat anti-MyBPC3, Santa 
Cruz sc-50115; MLC-2, Mouse anti-MLC, Sigma Aldrich M4401). Secondary antibodies 
conjugated with fluorescent dyes with infrared excitation spectra were used for detection. 
One- or two-color infrared western blots were scanned (Odyssey Infrared Imaging System, 
LI-COR Biosciences) and the images were analyzed. The integrated optical density of each 
protein expression on western blot was divided by the integrated optical density of actin on 
Ponseau-S stain (Sigma-Aldrich P7170) in order to normalize for loading. 
 
In the phosphorylation studies, SDS-PAGE (4–20% acrylamide gradient) was used for 
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separation of myofilament proteins. The gels were fixed in 100 ml of 50% methanol and 10% 
acetic acid. Gels were washed three times with 100 ml of ultrapure water for 10 min each, 
followed by staining in 60 ml of Pro-Q Diamond (Molecular Probes; Invitrogen P33300), for 
60-90 min under gentle agitation in the dark. The gels were destained 3 times, for 30 
minutes each in 100ml of solution containing 20% Acetonitrile, 50mM sodium acetate, pH 4 
and ultrapure water. The gels were scanned with a Typhoon 9400 (Amersham Biosciences), 
excitation filter 532 nm and emission filter 560 nm band pass. Then the gels were stained 
with Coomassie blue and scanned with an Epson Expression 1680 scanner. The images 
were analyzed with One-D scan EX software (Scanalytics Inc., Rockville, MD, USA). The 
integrated optical density of the Pro-Q diamond stain was divided by the integrated optical 
density of the Coomassie blue stain in order to normalize for protein loading. 
Isolated Heart Experiments.  An isolated heart setup was used to determine the 
developed and diastolic pressure to volume relationship (P - V) in hearts from N2B WT and 
KO mice. We used 6-month-old male KO and WT littermate mice (to ensure that the mice 
are as similar as possible).  Mice were anesthetized (60 mg/kg sodium pentobarbitone, i.p.) 
and heparinized (1,000 units/kg, i.p.) followed by rapid removal of the heart and cannulation 
of the aorta with a blunted 17-gauge needle for retrograde coronary perfusion with 
oxygenated Krebs solution at a constant pressure of 80 mmHg (1 mmHg = 133 Pa) and a 
temperature of 37°C. A thin-walled balloon was filled with degassed water until passive 
pressure reached 5 mmHg. Pressure was measured with a catheter introduced into the 
center of the balloon. Hearts were field-stimulated at an interbeat interval of 250 ms and 
were beating at a baseline volume (VBL) that resulted in a passive pressure of ~5 mmHg.  
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[Note that this is lower than the ~10Hz frequency encountered in vivo.]  Single-beat 
analysis of LV function was performed by changing LV filling V from 90% to 125% of VBL in 
5% increments to generate Frank-Starling curves, and records were collected for the full set 
of eight commanded volumes. Pressures were measured during test beats imposed after 
the heart had been beating isovolumically for 30 s at VBL to allow sufficient time for the 
preparation to stabilize fully. Diastolic pressure (Pd) was measured as the lowest LV 
pressure at the end of the test beat. Peak systolic pressure was measured from the test 
beat as well, and developed pressure (Pdev) was calculated as peak systolic pressure minus 
diastolic pressure. To account for possible changes in geometry, P was converted to wall 
stress (σ) by using a thick-walled spherical model: σ = P/[(Vw/V + 1)2/3 -1], where Vw is the 
volume of LV wall (LV weight /1.05). The Frank-Starling protocol was run first at baseline, 
then the response to β-adrenergic stimulation (0.2 mM dobutamine) and β-adrenergic 
blockade (0.1 mM propranolol) was determined.  Stable responses to dobutamine and 
propranolol were achieved after perfusion for 5 min each.  
Statistical analysis 
Data are expressed as mean ± SEM.  A t-test or where appropriate ANOVA with Scheffe’s 
posthoc test, was used with statistical significance at p<0.05. (Significance symbols on 
Figures and in Tables (*, #) one symbol: p<0.05; two symbols: p<0.01; three symbols: 
p<0.001).  Isolated heart results were from 6 WT and 6 KO mice and skinned muscle 
results from 8 WT and 8 KO mice (genotypes confirmed at the protein level, see Results). 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 13
Results 
We first evaluated how suitable the N2B KO model is to study the effect of titin-based 
passive tension on the length dependence of activation (LDA).  N2B KO mice express a 
mutant titin that is missing the N2B element, one of the three spring elements of cardiac titin 
[20].  The N2B element represents ~90 kDa of protein and its absence in mutant titin is on 
high resolution titin gels just detectable as a titin mobility shift, relative to the mobility of WT 
titin, allowing us to confirm the genotype of the mice (Fig. 1A).  Titin-based passive tension 
at SL 2.1 and 2.3 µm (measured 5 min after stretch) were significantly higher in KO mice 
(Fig. 1B, Table 1).   Mouse myocardium also expresses a low level of N2BA titin and we 
determined the N2BA to N2B expression ratio in WT and KO myocardium.  We found that 
the ratio was significantly greater in KO (0.30±0.02) than WT (0.23±0.01) myocardium (see 
inset of Supplementary Figure 1).  The predicted effect of co-expressing N2BA titin on 
passive force is a small force reduction (see broken lines in Supplementary Figure 1); this 
reduction is much smaller than the increase in force that results from the deletion of the N2B 
element (Supplementary Figure 1).  Because the extracellular matrix (ECM) also 
contributes to passive force, we measured its force contribution by extracting thick and thin 
filaments at the end of each experiment, thereby removing titin’s anchors in the sarcomere 
[25].  We determined collagen-based based tension as the tension that remained after 
extraction: 12% (±2.2%) and 10% (±1.5%) of total passive tension was collagen-based 
passive tension in KO and WT (SL 2.3 µm), respectively. No significant difference existed 
between WT and KO mice.  We also evaluated expression levels of collagens type I, III and 
V and included in our analysis an evaluation of the extracellular matrix protein fibronectin, 
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but found no difference between WT and KO myocardium (see supplementary figure 2A).  
This is consistent with the lack of a difference in collagen staining of histological sections 
(see supplementary figure 2B).  Thus the main effect of the deletion of the N2B element is 
an increase in titin-based passive force of the N2B cardiac titin isoform.   
 
We also evaluated expression levels and the phosphorylation status of isoforms of thin- and 
thick- filament proteins in N2B KO and WT myocardium, focusing on cardiac myosin binding 
protein-C (cMyBP-C), cardiac troponin T (cTnT), cardiac troponin I (cTnI), α-tropomyosin (α-
Tm), and myosin light chain-2 (MLC-2).  Antibodies to these proteins were used in a 
Western blot analysis, with protein loading normalized to Ponceau-S stained protein.  No 
differences were visually detectable between WT and KO mice (Fig. 2A, left) and 
quantitative analysis also revealed no significant differences (Fig. 2B, left).  Analysis of 
myosin heavy chain (MHC) isoform expression revealed that only αMHC is expressed in 
myocardium of KO and WT mice (Fig. 2A, bottom).  The phosphorylation status of cMyBP-
C, cTnT, cTnI, α-Tm and MLC-2 was assessed by Pro-Q diamond staining, a method for 
staining phosphoproteins (Molecular probes/Invitrogen).  No obvious differences were 
apparent between WT and KO tissue (Fig. 2A, right).  Pro-Q diamond staining was 
normalized to protein levels determined by staining the gels, subsequent to Pro-Q diamond 
staining, with Coomassie blue.  This analysis revealed no significant differences between 
WT and KO mice (Fig. 2B, right).   Thus, neither the protein levels of cMyBP-C, cTnT, cTnI, 
α-Tm, MLC-2, MHC nor their phosphoylation levels were altered between WT and KO mice.  
The only difference that was detected in the skinned myocardium of the N2B KO mice was 
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the smaller titin isoform.  Thus it appears that the N2B KO model is well suited to study the 
effect of increased passive tension on LDA, without confounding changes in other 
myofilament proteins.   
 
The calcium dependence of active tension development in skinned LV myocardium was 
measured at three different SLs: 1.95, 2.1 and 2.3 µm, using a protocol explained in Fig. 3A. 
The muscle was stretched in relaxing solution to a SL of either 2.1 or 2.3 µm (1.95 µm was 
close to the slack length (WT: 1.95 ± 0.01 µm; KO: 1.94 ± 0.01 µm) and was preset as the 
base length). [Note that previously we reported a reduction in slack SL in the N2B KO [20].  
The lack of a difference in the present work might be due to either the different method that 
was used in the present work to find the slack SL (length at which preparation is just taut vs. 
free floating myocytes in the previous [20]) or due to the presence of ECM in the present 
work.]  We used a constant stretch speed (20% L0/s) and then held the muscle length 
constant for 9 min followed by a release back to 1.95 µm.  Passive tension increased 
during the stretch and partially relaxed during the hold phase, due to the well-known stress 
relaxation phenomenon [30].  When passive tension reached a near steady level, the 
relaxing solution was changed first to a pre-activating solution and then to activating 
solutions with progressively higher levels of calcium (expressed as pCa), followed by 
relaxing solution and a release back to SL 1.95 µm.   
 
The maximal active tension at pCa 4.5 increased from ~40 mN/mm2 to ~60 mN/mm2 when 
SL was increased from 1.95 to 2.3 µm with no significant differences between WT and KO 
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mice (Table 1).  Submaximal active tensions were expressed relative to the maximal 
tension at pCa 4.5 and results at the three SLs are shown for WT muscle in Fig. 3B and for 
KO muscle in Fig. 3C.  The tension-pCa curves are shifted to the left when SL is increased, 
i.e., calcium sensitivity is length-dependent.  The Hill coefficients were slightly reduced at 
the longest SL (Table 1).  As a measure of calcium sensitivity we determined the pCa50 
(pCa at which tension was half of maximal); results shown in the insets of Figs. 3B and 3C 
and in Table 1 reveal that the KO myocardium has a significantly higher calcium sensitivity.  
Thus at a given submaximal calcium concentration, KO myocardium develops higher active 
tension.  Within the physiologically important pCa range of 5.8-6.2 [35] the tension increase 
varied from ~20% to ~40% at SL 2.1 µm and ~20 to ~90% at SL 2.3 µm (Fig. 4).  The 
length dependence of activation (LDA) was determined from the ∆pCa50.  Significantly 
higher ∆pCa50 values were obtained in the KO mice when SL was increased from either 1.95 
to 2.3 or from 2.1 to 2.3 µm (Table 1).  The difference in length-dependent activation at SLs 
1.95 and 2.3 µm is shown in Fig. 5A.  The KO mice clearly have a significantly larger left 
shift in the tension–pCa curve than the WT mice.  Fig. 5B shows a scattergram of the LDA 
results (SL 1.95 to 2.3 µm) of all WT and KO preparations.  LDA is significantly correlated 
with titin-based passive tension.  
 
In order to rule out that the difference in LDA between WT and KO myocardium was due to a 
difference in baseline phosphorylation (even though the phosphorylation analysis shown 
above did not reveal a difference), we performed a second series of experiments in which 
we first measured the force-pCa relation at SL 1.95 µm and 2.3 µm (to make the protocol 
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doable we omitted the middle SL),  PKA treated the preparation (see Methods for details), 
and measured again the force-pCa curves at the two SLs.  PKA-induced phosphorylation 
did not affect the maximal active tension, however, it significantly reduced pCa50 at both 
SL1.95 and 2.3um, regardless of genotype (Table 2).  Importantly, following PKA treatment, 
LDA (ΔpCa50) was significantly greater in KO compared to WT myocardium (Table 2).  A 
positive correlation between titin-based passive tension and LDA was found before (p<0.01) 
and after (p<0.01) PKA incubation (Fig. 6); the slope of the relationship was significantly 
higher after PKA treatment (p<0.01).  
Isolated hearts were also studied and the FSM of the left ventricle (LV) was measured.  
Heart were constantly beating at 4 Hz, LV volume was changed during the diastolic interval, 
and the first beat post-volume change was analyzed (no long-term changes in 
posttranslational modification will have taken place yet, ensuring that we assess only the 
intrinsic FSM, see also Discussion).  The volume was then changed back to the baseline 
volume and when a constant response was attained a test beat at a new volume was 
imposed.  To account for possible differences in geometry between WT and KO hearts, LV 
pressures were converted to wall stress (σ), see Methods.  A schematic of the setup and 
an example of a family of superimposed pre-and post-volume change twitches are shown in 
Figs. 7 A and B.  Diastolic wall stress (σd) was determined as the lowest stress at the end 
of the test beat (first beat post-volume change).  Developed wall stress (σdev) was 
calculated as peak systolic stress minus diastolic stress with measurements obtained in the 
presence of 0.2 mM dobutamine, or 0.1 mM propranolol. (See Discussion for details.)  An 
example of a set of σdev – volume and σd – volume curves of a WT and KO heart are shown 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 18
superimposed in Fig. 7C.  Both types of curves increased linearly with volume (R2 of linear 
fit typically 0.99) and summarized results of the slopes of the curves (i.e., stiffness) are 
shown in Table 3.  Under all experimental conditions, developed stiffness (i.e., the slope of 
the FSM) was significant larger in KO hearts (Table 2).  We plotted individual results from 
WT and KO hearts in Fig. 7D, and this shows that developed stiffness is positively 
correlated with diastolic stiffness (Fig. 7D).  Thus the FSM correlates with diastolic stiffness 
and is more pronounced in the N2B KO hearts. 
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Discussion 
To test the role of titin in the length-dependent increase in calcium sensitivity we used a 
mouse model in which titin’s N2B element has been deleted.  The N2B element is one of 
the three spring elements found in cardiac titin (the PEVK and tandem Ig segments are the 
two other elements) [36-38].  The N2B KO myocardium develops higher titin-based 
passive tension than WT myocardium (Fig. 1A), which can be explained as follows.  The 
N2B element is largely responsible for titin extension in sarcomeres longer than ~2.0 µm, 
(at shorter SLs, extension of the tandem Ig segments dominates, see [37]), and its 
absence in the KO results in a higher extension of the PEVK and tandem Ig segments [20].   
Because titin-based passive tension is entropic in nature, with tension increasing with the 
titin fractional extension [39], the increased extension of the tandem Ig segment and PEVK 
region of the N2B KO mice will result in a larger titin fractional extension and hence a 
higher passive tension.  The higher titin-based passive tension is likely to explain the 
increased LV diastolic stiffness in the N2B KO that was found in this study (Fig. 6B; Table 
2) and the diastolic dysfunction (reduced deceleration time of the early diastolic filling E 
wave and a restrictive filling pattern) that was revealed in a previous echocardiography 
study [20].  Thus the N2B KO mouse has elevated myocardial passive tension and is 
therefore well suited for testing the role of titin-based passive tension in the FSM of the 
heart. 
 
It is likely that the basis of the FSM is the increased myofilament calcium sensitivity at long 
SL [2, 3, 5], and to determine the role of titin-based passive tension in LDA we measured 
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force-pCa curves in skinned N2B KO and WT myocardium and evaluated LDA from the 
difference in the pCa50 values between long and short SLs.  The experiments revealed 
significantly larger LDA in the N2B KO with a positive correlation between titin-based 
passive tension and LDA (Fig. 5).  Because no differences were found in thin-and thick- 
filament protein expression or phosphorylation (Fig. 2), it is likely that the difference in LDA 
is due to the presence of the mutant titin isoform in N2B KO myocardium, which results in 
increased titin-based passive tension.  Although the titin-induced shift in the force-pCa 
relation might be viewed as modest, its effect on active tension is large at the 
physiologically important pCa levels of ~6.2-5.8 [35] (average increase of 28 % at SL 2.1 
µm and 51% at SL 2.3 µm).   
 
This study can be compared with previous work on mouse skinned cardiac myocytes in 
which the degree of passive stress relaxation prior to activation was varied and the 
relationship between the level of passive tension and LDA was measured [13].  Although 
there are subtle differences between the results of the two studies (the pCa50 levels are 
~0.05 units lower in single myocytes), both studies found a similar positive correlation 
between passive tension and LDA.  This relationship between passive tension and LDA in 
the mouse is also similar to that obtained in a study on skinned rat trabeculae, in which 
titin-based passive tension was varied by trypsin-based degradation of titin [30].  Finally, a 
positive correlation between passive tension and LDA was found previously by comparing 
left ventricular and left atrial bovine myocardium, which develop high and low passive 
tension, respectively [15].  The present study for the first time uses a genetic model to 
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address the role of titin in LDA.  Findings show that the N2B element is not required for 
LDA and that LDA is more pronounced in the N2B KO, strongly supporting the hypothesis 
that titin-based passive tension increases LDA.   
 
PKA-induced phosphorylation on thin- and thick- filament based proteins is known to affect 
calcium sensitivity in cardiac muscle (Matsuba et al. (2010), JGP 133(6), 571-).  
Specifically, it has been observed in studies that PKA phosphorylation of cTnI and MyBP-C 
leads to lower calcium sensitivity (Cazorla et al., 2006, Cardiovascular research 69 (370-
380); Kajiwara et al., 2000, Biochemical and Biophysical Research Communication 272 
(104-110)).  We also found a reduction in pCa50 and that the decrease was of a similar 
magnitude in KO and WT muscle.  Importantly, after PKA phosphorylation LDA was still 
significantly higher in the KO (Table 2, Fig. 6).  Thus titin-based passive tension 
correlation with LDA both before and after PKA treatment. 
 
The mechanisms by which titin increases LDA remain to be established.  Titin might affect 
LDA by either increasing calcium sensitivity at long SLs, or by lowering calcium sensitivity 
at short SLs.  Cazorla et al [13] and Fukuda et al [15] obtained experimental evidence for 
the former, and proposed that titin-based passive tension increases calcium sensitivity at 
long SLs because of the compressive effect of titin-based passive tension on the spacing 
between thin and thick filaments.  However, the work by de Tombe and colleagues has 
challenged the importance of lattice spacing for calcium sensitivity [2, 40, 41] and it seems 
worthwhile, therefore, to also consider other mechanisms.  Mechanisms that have been 
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proposed include passive tension-based thick filament strain that promotes crossbridge 
interaction [13, 14] and an effect of titin on thin filament activation [9].  The latter 
hypothesis is supported by various studies that have established that titin interacts with the 
thin filament (most likely through a PEVK-actin interaction [42-44]), and if this interaction 
were to inhibit calcium sensitivity at short SL, while at long SL the inhibition is relieved 
(when strained, titin might pull away from the thin filament) the present findings could be 
explained.  Clearly, more work is needed to understand how titin-based passive tension 
exerts its affect on LDA.    
 
The physiological significance of the skinned muscle findings was addressed in isolated 
heart experiments.  A single-beat technique was used in which a train of stable isovolumic 
beats is interrupted with a single perturbed beat at a new diastolic volume [45]. This 
protocol measures the intrinsic FSM, and avoids changes in the contractile state that occur 
during sustained beating at a new diastolic volume (the so-called slow force response to 
stretch that involves changes in phosphorylation of sarcomeric and calcium-handling 
proteins [46]).  Because it is known that the FSM becomes steeper in response to beta-
adrenergic stimulation [47, 48], and to exclude that our results are confounded by 
differences in beta-adrenergic ‘tone’ between WT and KO hearts, measurements were 
performed in the presence of the beta-adrenergic agonist dobutamine or antagonist 
propranolol.   The slope of the FSM was significantly higher in the N2B KO both in the 
presence of dobutamine or propranolol (Table 2).  The increased FSM in the N2B KO 
hearts and the positive correlation between the slope of the FSM and diastolic stiffness 
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(Fig. 7D) is consistent with the skinned muscle results and indicates that the effect of titin-
based tension on calcium sensitivity plays a significant role in the FSM of the heart. This is 
also supported by the results of an echocardiography study which showed that N2B KO 
hearts are hyper-contractile and have a larger ejection fraction than WT hearts [20]. 
 
Summary.  The increase in calcium sensitivity at long sarcomere length is more 
pronounced in skinned myocardium of the N2B KO mouse and this increase correlates 
with titin-based myocardial tension.  Isolated heart experiments reveal that the Frank-
Starling mechanism is more pronounced in the N2B KO model, supporting that the titin-
based increase in calcium sensitivity is physiologically relevant.  Thus, the present work 
supports that titin-based passive tension increases calcium sensitivity and is a contributing 
factor to the Frank-Starling mechanism of the heart. 
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Captions 
 
Figure 1.  Characterization of the N2B KO mouse model. (A) Titin expression in LV 
myocardium of WT and N2B KO mice (1% agarose gels).  WT myocardium of the mouse 
expresses predominately N2B titin with a small level of N2BA titin.  In the KO both N2B 
titin and N2BA titin have a slightly higher mobility than in the WT, consistent with the 
excision of the N2B element. (B) Titin-based passive tension in WT and N2B KO skinned 
myocardium (results from 8 WT and 8 KO mice).  (Tension is steady-state tension and 
was measured after 5 min stress relaxation.)  Asterisks: comparison between KO and WT 
myocardium. 
 
Figure 2.  Expression level and phosphorylation status of thin- and thick- filament 
proteins.  A) Left top: Representative Western blots (WBs) of cMyBP-C, cTnT, cTnI, α-
Tm, and MLC-2 in WT and KO left ventricular (LV) myocardium.  Left bottom: MHC gels 
loaded with WT and N2B KO LV myocardial proteins and bovine left ventricular (BLV) 
proteins.  Right: Pro-Q diamond (Pro-Q) stained 4-20% gradient gels.  B) Left: 
expression analysis; right: phosphorylation analysis.  Protein expression levels (n=6 per 
genotype) and phosphorylation levels (n=8 per genotype) in KO are not significantly 
different from WT. 
 
Figure 3. Force–pCa relations in WT and N2B KO skinned myocardium.  (A) 
Explanation of experimental protocol. The preparation was stretched, held for 9 min and 
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then released.  During the hold phase, the muscle was first in relaxing solution (pCa ~9.0), 
followed by pre-activating solution (Pre-A) and pCa 6.05, 5.85, 5.75, 5.6, 4.5 activating 
solutions, and finally relaxing solution again. Passive tension was measured just prior to 
activation and active tension in each activating solution was measured from the steady-
state tension (arrows) minus passive tension. Active tensions were normalized by the 
maximal active tension at pCa 4.5. (B and C) Average tension-pCa curves and pCa50 
(inset) of WT (B) and KO (C) at SL 1.95, 2.1, and 2.3 µm. In both genotypes, increasing 
sarcomere length left-shifts the tension-pCa curves and increases pCa50 values.  Results 
from 8 WT and 8 KO mice.  Asterisks: comparison between different sarcomere lengths in 
each genotype. 
 
Figure 4.  Tension increase in KO at submaximal calcium levels.  Active tensions of 
KO myocardium are expressed relative to those of WT.  At all pCa’s (except pCa 5.5) 
tensions are significantly higher in KO than in WT muscles. Results from 8 WT and 8 KO 
mice.  KO/WT ratio is significantly greater than 1 at SL2.1um (asterisks) and SL2.3um 
(number sign). 
 
Figure 5.  Length dependence of activation in WT and N2B KO skinned myocardium.   
(A) Average tension-pCa curves of WT (open symbols) and KO (closed symbols) at SL 
1.95 and 2.3µm. Inset, ΔpCa50 values (asterisks: comparison between WT and KO).  (B) 
ΔTitin-based passive tension is significantly correlated with LDA (ΔpCa50 from SL1.95 to 
2.3µm) in WT (open symbols) and KO (closed symbols) myocardium. Dashed line is the 
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linear regression fit (p<0.002).  Results from 8 WT and 8 KO mice 
 
Figure 6.  Length dependence of activation in WT and N2B KO skinned myocardium 
before and after PKA treatment.   ΔTitin-based passive tension is significantly 
correlated with LDA (ΔpCa50 from SL1.95 to 2.3µm) in WT (open symbols) and KO (closed 
symbols) myocardium. Dashed line is the linear regression fit (p<0.002).   
 
Figure 7. Assessment of FSM in isolated hearts.  (A) Left: Schematic of isolated heart 
setup.  The heart is perfused, twitch activated, and a small fluid-filled balloon, introduced 
into the LV and connected to a fast servomotor, rapidly changes LV volume; a pressure 
sensor inserted in the balloon measure LV pressure.  (B) Superimposed family of set of 
contractions before and after (test contraction) volume change.  Pressure was converted 
to wall stress (σ) and developed stress (σdev) and diastolic stress (σd) were determined.  
(C) Example of results of control (open symbols) and KO heart (closed symbols) obtained 
in the presence of dobutamine.  Note that the developed stress (σdev) – volume relation is 
steeper in the KO than in the WT heart.  (D) Developed stiffness (slope of σ - volume 
relation) is positively correlated with diastolic stiffness (p<0.01).  Individual results from 
WT and KO hearts are shown.  Inset: comparison of mean values (asterisks: comparison 
between WT and KO).  Results from 6 WT and 6 KO mice 
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Supplemental Figure 1.  Single molecule force-SL simulations.  We calculated the 
force of a single N2B and a single N2BA titin molecule in WT and N2B KO mice (solid 
lines) and the average force of a single molecule in WT and KO sarcomere taking into 
account the N2BA: N2B expression ratio (inset), see broken lines.  Expression of N2BA 
titin in a N2B dominant background reduces force, but the effect is small.  The main effect 
of the N2B deletion is the large increase in force of the N2B titin isoform.    
 
Details: We calculated the force—SL relations of single titin molecules using the 
wormlike chain WLC equation: 
4
1
)/1(4
1)(
2 −−+= LzL
z
Tk
PLFx
B
 (1) 
where F is force (in pN), kB is Boltzmann’s constant, T is absolute temperature, PL 
and L are the persistence and contour lengths. We serially-linked three WLCs, 
representing the combined tandem Ig segments, the PEVK, and N2B-Us spring 
elements. We assumed a PEVK contour length (CL) of 70 nm in N2B titin and 300 
nm in N2BA titin; CL of tandem Ig segments were set at 200 nm in N2B titin and 300 
nm in N2BA titin; CL of N2B Us was 200 nm for both isoforms.  The assumed 
persistence lengths (PL) were 1.3 nm, 12 nm and 0.65 nm, respectively.  We then 
calculated the force-SL relation of a single titin molecule and compared results for 
WT N2B titin, WT N2BA titin, KO N2B and KO N2BA titin and the average force-SL 
relation for sarcomeres that coexpress N2B and N2BA titins. For additional details 
on the assumed contour length, see (Trombitas et al. Biophys J 2000;79(6):3226-
34) .  For details on the assumed PL values, see Watanabe et al., JCB, 2002, 
29;277(13):11549-58. 
 
Supplemental Figure 2.  Assessment of extracellular matrix proteins in myocardium 
of WT and N2B KO mice.  A) Mean (±SEM) of collagen (type I, III, V) and fibronectin 
(FN) expression levels using qPCR (TaqMan) for N2B WT and KO mice (n=6 per 
genotype).  Data was normalized first to 18S, and then to WT.  No significant differences 
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were found between genotypes. B) Example of Trichrom staining of left ventricular 
myocardium from N2B WT and KO mice.  N2B KO myocadium shows comparable 
staining of collagen (blue) with no signs of fibrosis.   
 
 
References 
 
 Table 1. Mean ± SEM of passive and active tension (T) in WT and N2B KO 
myocardium (n=8 per genotype). 
 
 SL  passive T  max act.T ∆max T   nH  pCa50 SL range  ∆pCa50  
   (µm)  (mN/mm2)  (mN/mm2)   (%)   (µm) 
WT 1.95 -------   42±2   ------ 2.7±0.06   5.71±0.02 1.95–2.1  0.09±0.01 
WT 2.1 0.6±0.1   53±2  125±2 2.9±0.08   5.80±0.01 2.1–2.3 0.06±0.01  
WT 2.3 3.5±0.4   60±3  142±3 2.6±0.09   5.86±0.01 1.95–2.3   0.15±0.01 
KO 1.95 -------   44±3   ------ 2.7±0.05    5.76±0.01* 1.95–2.1  0.09±0.01 
KO 2.1 1.1±0.02***   56±4   127±3 2.8±0.07    5.84±0.01* 2.1–2.3   0.10±0.01** 
KO 2.3 10.7±0.4***   63±4  144±5 2.1±0.09**  5.94±0.010***  1.95–2.3  0.19±0.01*** 
Asterisks: comparison between KO and corresponding WT data (t-test); ∆Max T: maximal active 
tension difference from value at SL 1.95 µm; ∆pCa50 values apply to the SL range in the preceding 
column. 
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Table 2. Mean±SEM of passive tension (PT) and active tension (AT) in WT and 
N2B KO myocardium (n=5 per genotype) before and after PKA treatment.   
 SL     PT    Max AT    nH      pCa50         ∆pCa50 
   (µm)  (mN/mm2)   (mN/mm2)     
WT 1.95 -------   39±2 2.9±0.05     5.79±0.01        ------ 
WT 2.3 6.6±1.5   50±3 2.2±0.11     5.92±0.02       0.13±0.01 
PKA- WT 1.95 -------   41±3 2.7±0.06#    5.70±0.02## ------ 
PKA- WT 2.3 6.0±1.3#   52±4 2.0±0.07#    5.89±0.02##    0.19±0.02# 
KO 1.95 -------   42±3    2.7±0.06    5.81±0.02        ------ 
KO 2.3 16.5±1.1***   48±3    2.7±0.02**   6.01±0.01**    0.21±0.02** 
PKA- KO 1.95 -------   42±3  2.6±0.09    5.72±0.02## ------ 
PKA- KO 2.3 15.0±1.1***/###  48±3 1.5±0.04***/#  5.99±0.01**/##   0.27±0.02**/## 
Asterisks: comparison between KO and corresponding WT data (t-test); 
Number sign: comparison between before and after PKA incubation; 
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Table 3. Mean±SEM of Diastolic and developed LV stiffness (n=6 per genotype)  
 Diastolic stiffness Developed stiffness 
Treatment WT KO WT KO 
Dobutamine 2.9±0.3 6.1±0.7## 7.0±0.4  10.1±1.2 # 
Propranolol 3.2±0.3* 6.1±0.7# 4.0±0.4**   5.9±0.6**/ # 
Stiffness: slope of wall stress (in mmHg) vs. LV volume (in µl) relation; Asterisks: comparison 
between dobutamine and propranolol results using a paired t-test; Number sign: comparison 
between WT and corresponding KO result using a t-test.   
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